Crossmark

Where to start? A two stage residual inclusion approach to estimating influence of the initial provider on health care utilization and costs for low back pain in the US

Crossref DOI link: https://doi.org/10.1186/s12913-022-08092-1

Published Online: 2022-05-23

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harwood, Kenneth J.

Pines, Jesse M.

Andrilla, C. Holly A.

Frogner, Bianca K.
License Information

Text and Data Mining valid from 2022-05-23

Version of Record valid from 2022-05-23
More Information

Article History

Received: 29 June 2021

Accepted: 9 May 2022

First Online: 23 May 2022

Declarations

:

: Our study was approved by The George Washington University Institutional Review Boards (IRB #011814). All experiment protocol for involving humans was in accordance to guidelines of national/international/institutional or Declaration of Helsinki in the manuscript. A waiver for consent was given by The George Washington University IRB. Our research team had a signed data agreement with HCCI that is re-examined annually to access the proposed dataset. HCCI was the holder of the identifiers, and prohibited the release of the identifiers to the study team.

: Not applicable.

: KH: Current funding form Lewin group, under contract with the US Centers for Medicare and Medicaid for unrelated work.JP: Consultant to CSL Behring, Medtronic, NovoNordisk and Abbott Point-of-Care on unrelated work.BF & HA have no competing interests

Document is current

Any future updates will be listed below